Assessment of an Adherent HEK293 Cell Transfection Process for Scalable AAV Production in the iCELLis® 500 Fixed-Bed Bioreactors

被引：0
|
作者：
Kaspar, Brian K. [1 ]
Gardell, Brian [2 ]
Chung, Keen [2 ]
Vallabhaneni, Deepika [2 ]
Legmann, Rachel [2 ]
机构：
[1] AveXis Inc, Bannockburn, IL USA
[2] Pall Life Sci, Westborough, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
478
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [1] Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures
    Ho, Y. K.
    Too, H. P.
    [J]. GENE THERAPY, 2020, 27 (10-11) : 482 - 494
  • [2] Development of a laboratory scalable process for enhancing lentivirus production by transient transfection of HEK293 adherent cultures
    Y. K. Ho
    H. P. Too
    [J]. Gene Therapy, 2020, 27 : 482 - 494
  • [3] DMSO Promotes AAV Production in Scalable Suspended HEK293 Cells
    Xie, Chang
    Mak, Wayne
    Coble, Christopher
    Sen, Dwaipayan
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 457 - 457
  • [4] Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells
    Blessing, Daniel
    Vachey, Gabriel
    Pythoud, Catherine
    Rey, Maria
    Padrun, Vivianne
    Wurm, Florian M.
    Schneider, Bernard L.
    Deglon, Nicole
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 14 - 26
  • [5] Development and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis® Fixed-Bed Bioreactor
    Powers, Alicia D.
    Piras, Bryan A.
    Clark, Robert K.
    Lockey, Timothy D.
    Meagher, Michael M.
    [J]. HUMAN GENE THERAPY METHODS, 2016, 27 (03) : 112 - 121
  • [6] Development and upscale of HEK293 triple transfection process in single-use bioreactors for industrial manufacture of AAV vectors
    Guianvarc'h, L.
    Boussicault, F.
    Le Bec, C.
    Mingozzi, F.
    Mavilio, F.
    Hebben, M.
    [J]. HUMAN GENE THERAPY, 2015, 26 (10) : A70 - A71
  • [7] Clarification Studies on HEK293 Cell Lysate for AAV Production
    Gursky, Blake
    Belcher, Donald
    Davis, Corben
    Bodey, Elijah
    Yung, Bryant
    Davis, Adam
    Agbogbo, Frank
    Dismuke, David
    [J]. MOLECULAR THERAPY, 2022, 30 (04) : 190 - 190
  • [8] Optimized media, transfection, and bioreactor parameters for HEK293 production of AAV-2
    Schrag, K. S.
    Haywood, J. J.
    McLaughlin, K. A.
    Stegemann, N. S.
    Hellman, K. A.
    [J]. HUMAN GENE THERAPY, 2022, 33 (23-24) : A103 - A104
  • [9] Transferring Viral Vector Production from Plasticware to a Fixed-Bed Bioreactor: Proof-of-concept from Univercells for scalable HEK293 cell growth and adenovirus production
    Dohogne, Yael
    Collignon, Florence
    Drugmand, Jean-Christophe
    Chatel, Alex
    Castillo, José
    Kumano, Satoshi
    Shiomi, Hitoshi
    [J]. Genetic Engineering and Biotechnology News, 2019, 39 (02): : 60 - 62
  • [10] Retroviral vector manufacturing production using disposable fixed-bed bioreactors iCELLis® nano
    Cota, M.
    Allievi, L.
    Neri, M.
    Bellintani, F.
    Crippa, L.
    Mangia, P.
    Arnaudova, R.
    Catamancio, S. La Seta
    Pedregal, A.
    Rizzardi, G. P.
    Vallanti, G.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A92 - A92
12345